Reviva Pharmaceuticals I... (RVPHW)
undefined
undefined%
At close: undefined
0.31
-4.38%
After-hours Dec 13, 2024, 03:59 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - - - -
Cost of Revenue - - - 724.74K - -
Gross Profit - - - -724.74K - -
Operating Income -39,503.60B -24.31M -10.10M -2.43M -376.86K -1.12M
Interest Income - 182.80K - 105.18K 201.00 -
Pretax Income -39.24M -24.32M -8.52M -3.78M -846.03K -1.68M
Net Income -39,260.80B -24.34M -8.52M -3.78M -846.83K -1.68M
Selling & General & Admin 8,083.80B 5.36M 5.25M 2.14M 181.12K 175.58K
Research & Development 31,419.80B 18.95M 4.85M 295.15K 195.74K 946.30K
Other Expenses - - - - - -0.00
Operating Expenses 39,503.60B 24.31M 10.10M 2.43M 376.86K 1.12M
Interest Expense - 182.80K 2.41K 1.45M 469.37K -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 39.50M 24.31M 10.10M 2.43M 376.86K 1.12M
Income Tax -16.95B 20.78K 6.00K 800.00 800.00 800.00
Shares Outstanding (Basic) 23.80M 19.52M 14.79M 3.06M 2.77M -
Shares Outstanding (Diluted) 23.80M 19.52M 14.79M 3.06M 2.77M -
EPS (Basic) -1.65 -1.25 -0.58 -1.24 -0.31 -
EPS (Diluted) -1.65 -1.25 -0.58 -1.24 -0.31 -
EBITDA -39,503.60B -24.11M -10.10M -2.33M -376.01K -1.12M
Depreciation & Amortization - 194.71K 236.56K 105.77K 846.00 1.02K